RYSTIGGO 140 MG / ML SOL INJ CT FR VD INC X 3 ML (420 MG)
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1236100980022 -
GGREM
525226070029307 -
Código de barras
5413787224319
O que a fonte publica
- Detentor do registro
- UCB BIOPHARMA LTDA.
- Princípios ativos
- ROZANOLIXIZUMABE
- Embalagem
- 140 MG / ML SOL INJ CT FR VD INC X 3 ML (420 MG)
- Tipo de produto
- Biológico
- Classe terapêutica
- M5X - TODOS OS OUTROS FÁRMACOS COM AÇÃO MÚSCULO-ESQUELÉTICA
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "RYSTIGGO 140 MG / ML SOL INJ CT FR VD INC X 3 ML (420 MG)",
"holder": "UCB BIOPHARMA LTDA.",
"stripe": null,
"barcodes": [
"5413787224319"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "525226070029307",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "64.711.500/0001-14",
"priceRegime": "Regulado",
"productName": "RYSTIGGO",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "140 MG / ML SOL INJ CT FR VD INC X 3 ML (420 MG)",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "39536.90",
"icms-12": "44928.31",
"icms-17": "47634.81",
"icms-18": "48215.72",
"icms-19": "48810.99",
"icms-20": "49421.13",
"icms-21": "50046.72",
"icms-22": "50688.32",
"icms-23": "51346.61",
"icms-17.5": "47923.51",
"icms-19.5": "49114.16",
"icms-20.5": "49731.96",
"icms-22.5": "51015.37",
"icms-12-alc": "40114.57",
"icms-17-alc": "42531.07",
"icms-18-alc": "43049.75",
"icms-19-alc": "43581.21",
"icms-20-alc": "44125.99",
"icms-21-alc": "44684.56",
"icms-22-alc": "45257.41",
"icms-23-alc": "45845.17",
"withoutTaxes": "35300.80",
"icms-17.5-alc": "42788.85",
"icms-19.5-alc": "43851.92",
"icms-20.5-alc": "44403.50",
"icms-22.5-alc": "45549.39"
},
"pisCofinsList": "Negativa",
"substanceText": "ROZANOLIXIZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "53037.34",
"icms-12": "60269.73",
"icms-17": "63900.40",
"icms-18": "64679.67",
"icms-19": "65478.21",
"icms-20": "66296.69",
"icms-21": "67135.89",
"icms-22": "67996.58",
"icms-23": "68879.65",
"icms-17.5": "64287.68",
"icms-19.5": "65884.90",
"icms-20.5": "66713.65",
"icms-22.5": "68435.30",
"icms-12-alc": "55456.04",
"icms-17-alc": "58796.71",
"icms-18-alc": "59513.75",
"icms-19-alc": "60248.47",
"icms-20-alc": "61001.59",
"icms-21-alc": "61773.78",
"icms-22-alc": "62565.71",
"icms-23-alc": "63378.26",
"withoutTaxes": "48801.28",
"icms-17.5-alc": "59153.07",
"icms-19.5-alc": "60622.71",
"icms-20.5-alc": "61385.23",
"icms-22.5-alc": "62969.36"
},
"invalidBarcodes": [],
"activeSubstances": [
"ROZANOLIXIZUMABE"
],
"therapeuticClass": "M5X - TODOS OS OUTROS FÁRMACOS COM AÇÃO MÚSCULO-ESQUELÉTICA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": "(AR)",
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1236100980022",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "M5X",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:525226070029307"